Literature DB >> 6292893

Nucleotide sequence of the ilvB promoter-regulatory region: a biosynthetic operon controlled by attenuation and cyclic AMP.

P Friden, T Newman, M Freundlich.   

Abstract

The DNA sequence of the promoter-regulatory region of the ilvB operon of Escherichia coli was determined. This region encodes a potential leader polypeptide containing 32 amino acids, 12 of which are the regulatory amino acids valine and leucine. Approximately 50 residues downstream from the coding region for the potential leader peptide is a site for terminating transcription. In vitro transcription experiments show that transcription terminates at this site and produces a leader mRNA of approximately equal to 188 nucleotides. A model for the multivalent regulation of this operon by valyl- and leucyl-tRNA is proposed on the basis of the mutually exclusive formation of five strong stem-and-loop structures in the leader mRNA. In addition, the -35 and -70 regions of this sequence show close structural homologies to areas in cyclic AMP receptor protein (CRP)-dependent promoters reported to be important for CRP function. In vitro transcription from the ilvB promoter was greatly increased by cyclic AMP and CRP. Taken together, these data strongly suggest that the ilvB biosynthetic operon is negatively controlled by multivalent transcription termination and is positively regulated by cyclic AMP and CRP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292893      PMCID: PMC347078          DOI: 10.1073/pnas.79.20.6156

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Chain length determination of small double- and single-stranded DNA molecules by polyacrylamide gel electrophoresis.

Authors:  T Maniatis; A Jeffrey; H van deSande
Journal:  Biochemistry       Date:  1975-08-26       Impact factor: 3.162

2.  DNAse footprinting: a simple method for the detection of protein-DNA binding specificity.

Authors:  D J Galas; A Schmitz
Journal:  Nucleic Acids Res       Date:  1978-09       Impact factor: 16.971

3.  Cyclic AMP can replace the relA-dependent requirement for derepression of acetohydroxy acid synthase in E. coli K-12.

Authors:  M Freundlich
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

Review 4.  Regulation of bacterial growth, RNA, and protein synthesis.

Authors:  D P Nierlich
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

5.  Regulation of in vitro transcription of the tryptophan operon by purified RNA polymerase in the presence of partially purified repressor and tryptophan.

Authors:  J K Rose; C L Squires; C Yanofsky; H L Yang; G Zubay
Journal:  Nat New Biol       Date:  1973-10-03

6.  Activation of transcription at specific promoters by glycerol.

Authors:  S Nakanishi; S Adhya; M Gottesman; I Pastan
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

7.  Stability of ribonucleic acid double-stranded helices.

Authors:  P N Borer; B Dengler; I Tinoco; O C Uhlenbeck
Journal:  J Mol Biol       Date:  1974-07-15       Impact factor: 5.469

8.  Improved estimation of secondary structure in ribonucleic acids.

Authors:  I Tinoco; P N Borer; B Dengler; M D Levin; O C Uhlenbeck; D M Crothers; J Bralla
Journal:  Nat New Biol       Date:  1973-11-14

9.  Termination of transcription in vitro in the Escherichia coli tryptophan operon leader region.

Authors:  F Lee; C L Squires; C Squires; C Yanofsky
Journal:  J Mol Biol       Date:  1976-05-15       Impact factor: 5.469

10.  Transcription termination at the trp operon attenuators of Escherichia coli and Salmonella typhimurium: RNA secondary structure and regulation of termination.

Authors:  F Lee; C Yanofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  49 in total

Review 1.  Cyclic AMP in prokaryotes.

Authors:  J L Botsford; J G Harman
Journal:  Microbiol Rev       Date:  1992-03

2.  Pleiotropic effects of poxA regulatory mutations of Escherichia coli and Salmonella typhimurium, mutations conferring sulfometuron methyl and alpha-ketobutyrate hypersensitivity.

Authors:  T K Van Dyk; D R Smulski; Y Y Chang
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

Review 3.  Control site location and transcriptional regulation in Escherichia coli.

Authors:  J Collado-Vides; B Magasanik; J D Gralla
Journal:  Microbiol Rev       Date:  1991-09

4.  Analysis of the spacer DNA between the cyclic AMP receptor protein binding site and the lac promoter.

Authors:  U Flatow; G V Rajendrakumar; S Garges
Journal:  J Bacteriol       Date:  1996-04       Impact factor: 3.490

5.  Global expression profiling and physiological characterization of Corynebacterium glutamicum grown in the presence of L-valine.

Authors:  C Lange; D Rittmann; V F Wendisch; M Bott; H Sahm
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

6.  Molecular and functional characterization of Salmonella enterica serovar typhimurium poxA gene: effect on attenuation of virulence and protection.

Authors:  K Kaniga; M S Compton; R Curtiss; P Sundaram
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

7.  A computer algorithm for testing potential prokaryotic terminators.

Authors:  V Brendel; E N Trifonov
Journal:  Nucleic Acids Res       Date:  1984-05-25       Impact factor: 16.971

8.  Transcription attenuation in Salmonella typhimurium: the significance of rare leucine codons in the leu leader.

Authors:  P W Carter; J M Bartkus; J M Calvo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  Regulation of Caulobacter crescentus ilvBN gene expression.

Authors:  J C Tarleton; J Malakooti; B Ely
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

10.  Cloning, sequencing, and enhanced expression of the dihydropteroate synthase gene of Escherichia coli MC4100.

Authors:  W S Dallas; J E Gowen; P H Ray; M J Cox; I K Dev
Journal:  J Bacteriol       Date:  1992-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.